首页 | 本学科首页   官方微博 | 高级检索  
检索        

华蟾素抑制结肠癌细胞增殖转移的实验研究
引用本文:唐雪瑶,邱艳艳,殷佩浩.华蟾素抑制结肠癌细胞增殖转移的实验研究[J].上海中医药大学学报,2018,32(4):65-69.
作者姓名:唐雪瑶  邱艳艳  殷佩浩
作者单位:上海中医药大学附属普陀医院;上海中医药大学中西医结合肿瘤介入研究所;安徽医科大学上海普陀中心临床学院
基金项目:国家中医药管理局“十二五”中医药重点学科建设项目——中西医结合临床(A-167);上海市科委医学引导类项目(16411972600);上海中医药大学中西医结合高原学科面上项目(16-DX-08);上海市普陀区卫生系统“315”工程人才培养计划学科带头人项目(18Q-RC-01)
摘    要:目的:观察华蟾素对结肠癌细胞HCT116细胞增殖、迁移的影响,探讨其可能的作用机制。方法:常规体外培养结肠癌细胞HCT116细胞系,采用CCK-8法检测不同浓度华蟾素作用不同时间对HCT116细胞增殖的抑制作用,细胞划痕实验和Transwell小室法检测华蟾素对细胞迁移能力的影响,蛋白质印迹法(Western blot)检测细胞基质金属蛋白酶(MMP)-9、MMP-2、钙黏蛋白(E-Cadherin)的表达水平。结果:CCK-8法检测结果表明,华蟾素对HCT116细胞的生长有明显抑制作用,其抑制作用随药物浓度和作用时间的增加而增强(P0.05);细胞划痕实验和Transwell小室法结果显示,随华蟾素药物浓度的增加,HCT116细胞迁移能力下降(P0.05);Western blot结果表明,华蟾素能够明显抑制HCT116细胞MMP-9的蛋白表达并上调E-Cadherin的蛋白表达(P0.01),但对MMP-2蛋白的表达无显著影响(P0.05)。结论:华蟾素能够抑制人结肠癌细胞的增殖和转移,其机制可能与其抑制MMP-9和上调E-Cadherin的蛋白表达有关。

关 键 词:华蟾素  结肠癌细胞  细胞转移  基质金属蛋白酶  钙黏蛋白

Cinobufacini inhibits the proliferation and metastasis of HCT116 colon cancer cells
TANG Xueyao,QIU Yanyan and YIN Peihao.Cinobufacini inhibits the proliferation and metastasis of HCT116 colon cancer cells[J].Acta Universitatis Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai,2018,32(4):65-69.
Authors:TANG Xueyao  QIU Yanyan and YIN Peihao
Institution:Putuo Hospital of Shanghai University of Traditional Chinese Medicine,Shanghai 200062,China;Tumor Intervention Institute of Integrated Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200062,China,Putuo Hospital of Shanghai University of Traditional Chinese Medicine,Shanghai 200062,China;Tumor Intervention Institute of Integrated Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200062,China and Putuo Hospital of Shanghai University of Traditional Chinese Medicine,Shanghai 200062,China;Tumor Intervention Institute of Integrated Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200062,China;Shanghai Putuo Central Clinical College,Anhui Medical University,Shanghai 200062,China
Abstract:  Objective:To investigate the effects of cinobufacini on the proliferation and metastasis of human colon cancer cell line HCT116 and discuss its possible mechanism.   Methods:The colon cancer cell line HCT116 was cultured in vitro. The inhibitory effects of cinobufacini with different concentrations on the proliferation of HCT116 cells at different timepoints were detected by CCK-8 assay. The effects of cinobufacini on the migration were detected by cell scratch test and Transwell chamber assay. The expressions of MMP-9,MMP-2 and E-Cadherin were detected by Western blot.   Results:The results of CCK-8 assay showed that cinobufacini significantly inhibited the growth of HCT116 cells and the inhibitory effect was enhanced with the increase of drug concentration and time(P<0.05). The results of cell scratch test and Transwell chamber assay showed that with the increase of cinobufotalin concentration,HCT116 cell migration ability was decreased(P<0.05). The results of Western blot showed that cinobufotalin could obviously inhibit the protein expression of MMP-9 and up-regulate the protein expression of E-Cadherin in HCT116 cells(P<0.01),but there was no significant effect on the protein expression of MMP-2(P>0.05).   Conclusion:Cinobufacini can inhibit the proliferation and metastasis of human colon cancer cells. Its mechanism may be related to the inhibition on the protein expression of MMP-9 and up-regulation of E-Cadherin.
Keywords:cinobufacini  colon cancer cells  cell metastasis  matrix metalloproteinase  E-Cadherin
本文献已被 CNKI 等数据库收录!
点击此处可从《上海中医药大学学报》浏览原始摘要信息
点击此处可从《上海中医药大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号